Literature DB >> 16388332

RNA interference in neuroscience: progress and challenges.

Victor M Miller1, Henry L Paulson, Pedro Gonzalez-Alegre.   

Abstract

1.RNA interference (RNAi) is a recently discovered biological pathway that mediates post-transcriptional gene silencing. The process of RNAi is orchestrated by an increasingly well-understood cellular machinery. 2. The common entry point for both natural and engineered RNAi are double stranded RNA molecules known as short interfering RNAs (siRNAs), that mediate the sequence-specific identification and degradation of the targeted messenger RNA (mRNA). The study and manipulation of these siRNAs has recently revolutionized biomedical research. 3. In this review, we first provide a brief overview of the process of RNAi, focusing on its potential role in brain function and involvement in neurological disease. We then describe the methods developed to manipulate RNAi in the laboratory and its applications to neuroscience. Finally, we focus on the potential therapeutic application of RNAi to neurological disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16388332     DOI: 10.1007/s10571-005-8447-4

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  64 in total

1.  Local gene knockdown in the brain using viral-mediated RNA interference.

Authors:  Jonathan D Hommel; Robert M Sears; Dan Georgescu; Diana L Simmons; Ralph J DiLeone
Journal:  Nat Med       Date:  2003-11-23       Impact factor: 53.440

2.  Allele-specific silencing of a pathogenic mutant acetylcholine receptor subunit by RNA interference.

Authors:  Amr Abdelgany; Matthew Wood; David Beeson
Journal:  Hum Mol Genet       Date:  2003-08-19       Impact factor: 6.150

Review 3.  Looking backward to move forward: early detection of neurodegenerative disorders.

Authors:  Steven T DeKosky; Kenneth Marek
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

4.  A microRNA array reveals extensive regulation of microRNAs during brain development.

Authors:  Anna M Krichevsky; Kevin S King; Christine P Donahue; Konstantin Khrapko; Kenneth S Kosik
Journal:  RNA       Date:  2003-10       Impact factor: 4.942

5.  A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain.

Authors:  Hervé Seitz; Hélène Royo; Marie-Line Bortolin; Shau-Ping Lin; Anne C Ferguson-Smith; Jérôme Cavaillé
Journal:  Genome Res       Date:  2004-08-12       Impact factor: 9.043

6.  RNAi-induced gene silencing by local electroporation in targeting brain region.

Authors:  Yukio Akaneya; Bin Jiang; Tadaharu Tsumoto
Journal:  J Neurophysiol       Date:  2005-01       Impact factor: 2.714

7.  Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS.

Authors:  Cédric Raoul; Toufik Abbas-Terki; Jean-Charles Bensadoun; Sandrine Guillot; Georg Haase; Jolanta Szulc; Christopher E Henderson; Patrick Aebischer
Journal:  Nat Med       Date:  2005-03-13       Impact factor: 53.440

8.  Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs.

Authors:  Jürgen Soutschek; Akin Akinc; Birgit Bramlage; Klaus Charisse; Rainer Constien; Mary Donoghue; Sayda Elbashir; Anke Geick; Philipp Hadwiger; Jens Harborth; Matthias John; Venkitasamy Kesavan; Gary Lavine; Rajendra K Pandey; Timothy Racie; Kallanthottathil G Rajeev; Ingo Röhl; Ivanka Toudjarska; Gang Wang; Silvio Wuschko; David Bumcrot; Victor Koteliansky; Stefan Limmer; Muthiah Manoharan; Hans-Peter Vornlocher
Journal:  Nature       Date:  2004-11-11       Impact factor: 49.962

9.  siRNA-mediated gene silencing in vitro and in vivo.

Authors:  Haibin Xia; Qinwen Mao; Henry L Paulson; Beverly L Davidson
Journal:  Nat Biotechnol       Date:  2002-09-16       Impact factor: 54.908

10.  Activation of the interferon system by short-interfering RNAs.

Authors:  Carol A Sledz; Michelle Holko; Michael J de Veer; Robert H Silverman; Bryan R G Williams
Journal:  Nat Cell Biol       Date:  2003-08-24       Impact factor: 28.824

View more
  7 in total

1.  RNA interference-mediated inhibition of wild-type Torsin A expression increases apoptosis caused by oxidative stress in cultured cells.

Authors:  Xue-Ping Chen; Xiao-Hui Hu; Shu-Hui Wu; Yang-Wei Zhang; Bo Xiao; Hui-Fang Shang
Journal:  Neurochem Res       Date:  2010-05-09       Impact factor: 3.996

Review 2.  A neuroscientist's guide to transgenic mice and other genetic tools.

Authors:  Shaghayegh Navabpour; Janine L Kwapis; Timothy J Jarome
Journal:  Neurosci Biobehav Rev       Date:  2019-12-13       Impact factor: 8.989

Review 3.  Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis.

Authors:  Monica Nizzardo; Chiara Simone; Marianna Falcone; Giulietta Riboldi; Federica Rizzo; Francesca Magri; Nereo Bresolin; Giacomo P Comi; Stefania Corti
Journal:  Cell Mol Life Sci       Date:  2011-11-18       Impact factor: 9.261

4.  siRNA knock-down of mutant torsinA restores processing through secretory pathway in DYT1 dystonia cells.

Authors:  Jeffrey W Hewett; Flávia C Nery; Brian Niland; Pei Ge; Pamela Tan; Philipp Hadwiger; Bakhos A Tannous; Dinah W Y Sah; Xandra O Breakefield
Journal:  Hum Mol Genet       Date:  2008-02-07       Impact factor: 6.150

5.  Delivery systems for in vivo use of nucleic Acid drugs.

Authors:  R R Resende; H A M Torres; K K Yuahasi; Majumder P; Ulrich H
Journal:  Drug Target Insights       Date:  2007-08-09

6.  Efficient in vivo electroporation of the postnatal rodent forebrain.

Authors:  Camille Boutin; Simone Diestel; Angélique Desoeuvre; Marie-Catherine Tiveron; Harold Cremer
Journal:  PLoS One       Date:  2008-04-02       Impact factor: 3.240

7.  Hydrophobically Modified siRNAs Silence Huntingtin mRNA in Primary Neurons and Mouse Brain.

Authors:  Julia F Alterman; Lauren M Hall; Andrew H Coles; Matthew R Hassler; Marie-Cecile Didiot; Kathryn Chase; Jasmin Abraham; Emily Sottosanti; Emily Johnson; Ellen Sapp; Maire F Osborn; Marian Difiglia; Neil Aronin; Anastasia Khvorova
Journal:  Mol Ther Nucleic Acids       Date:  2015-12-01       Impact factor: 10.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.